Lee JS - Search Results

1

The incidence of second primary tumors in long-term survivors of small-cell lung cancer.

Heyne KH, Lippman SM, Lee JJ, Lee JS, Hong WK. Heyne KH, et al. Among authors: lee js, lee jj. J Clin Oncol. 1992 Oct;10(10):1519-24. doi: 10.1200/JCO.1992.10.10.1519. J Clin Oncol. 1992. PMID: 1328547

2

Phase II study of combination therapy with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small-cell lung cancer.

Shin DM, Dhingra HM, Lee JS, Fossella FV, Murphy WK, Hong WK. Shin DM, et al. Among authors: lee js. Am J Clin Oncol. 1992 Jun;15(3):194-9. doi: 10.1097/00000421-199206000-00003. Am J Clin Oncol. 1992. PMID: 1317094 Clinical Trial.

3

Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report.

Shirinian M, Lee JS, Dhingra HH, Greenberg J, Hong WK. Shirinian M, et al. Among authors: lee js. Semin Oncol. 1992 Dec;19(6 Suppl 12):58-63. Semin Oncol. 1992. PMID: 1336623 Clinical Trial.

4

Study of multidrug resistance (mdr1) gene in non-small-cell lung cancer.

Shin HJ, Lee JS, Hong WK, Shin DM. Shin HJ, et al. Among authors: lee js. Anticancer Res. 1992 Mar-Apr;12(2):367-70. Anticancer Res. 1992. PMID: 1374598

5

Expression of blood-group antigen A--a favorable prognostic factor in non-small-cell lung cancer.

Lee JS, Ro JY, Sahin AA, Hong WK, Brown BW, Mountain CF, Hittelman WN. Lee JS, et al. N Engl J Med. 1991 Apr 18;324(16):1084-90. doi: 10.1056/NEJM199104183241603. N Engl J Med. 1991. PMID: 1848917 Free article.

6

Ifosfamide with mesna uroprotection in the management of lung cancer.

Holoye PY, Glisson BS, Lee JS, Dhingra HM, Murphy WK, Umsawasdi T, Levy JK, Jeffries D, Raber MN, Hong WK. Holoye PY, et al. Among authors: lee js. Am J Clin Oncol. 1990 Apr;13(2):148-55. doi: 10.1097/00000421-199004000-00012. Am J Clin Oncol. 1990. PMID: 2156418

7

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, et al. Hong WK, et al. Among authors: lee js. N Engl J Med. 1990 Sep 20;323(12):795-801. doi: 10.1056/NEJM199009203231205. N Engl J Med. 1990. PMID: 2202902 Free article. Clinical Trial.

8

Primary chemotherapy of brain metastasis in small-cell lung cancer.

Lee JS, Murphy WK, Glisson BS, Dhingra HM, Holoye PY, Hong WK. Lee JS, et al. J Clin Oncol. 1989 Jul;7(7):916-22. doi: 10.1200/JCO.1989.7.7.916. J Clin Oncol. 1989. PMID: 2544685 Clinical Trial.

9

Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor.

Lee JS, Yoon A, Kalapurakal SK, Ro JY, Lee JJ, Tu N, Hittelman WN, Hong WK. Lee JS, et al. Among authors: lee jj. J Clin Oncol. 1995 Aug;13(8):1893-903. doi: 10.1200/JCO.1995.13.8.1893. J Clin Oncol. 1995. PMID: 7636531

10

Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.

Fossella FV, Lee JS, Berille J, Hong WK. Fossella FV, et al. Among authors: lee js. Semin Oncol. 1995 Apr;22(2 Suppl 4):22-9. Semin Oncol. 1995. PMID: 7740327 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,785 results

Search Page

Filters